LSE - Delayed Quote SEK

Xvivo Perfusion AB (publ) (0RKL.L)

194.90 -4.00 (-2.01%)

At close: 4:24:40 PM GMT

Interim Report January - September 2026

ACCESS Newswire 12d ago

XVIVO.ST

0RKL.L
-2.01%
3XV.F
Conference call on Interim Report July-September 2026

ACCESS Newswire 20d ago

XVIVO.ST

0RKL.L
-2.01%
3XV.F
Nomination Committee of XVIVO Perfusion AB (publ)

ACCESS Newswire 1mo ago

XVIVO.ST

BURE.ST

0RKL.L
-2.01%
XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System

ACCESS Newswire 1mo ago

XVIVO.ST

0RKL.L
-2.01%
3XV.F
XVIVO Receives CE Certificates for Its Groundbreaking Heart Preservation Technology, Transforming Access to Life-Saving Transplants Across Europe

ACCESS Newswire 2mo ago

XVIVO.ST

0RKL.L
-2.01%
3XV.F
XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport

ACCESS Newswire 2mo ago

XVIVO.ST

0RKL.L
-2.01%
3XV.F
Interim Report January - June 2026

ACCESS Newswire 3mo ago

XVIVO.ST

3XV.F

0RKL.L
-2.01%
Conference call on Interim Report April-June 2026

ACCESS Newswire 4mo ago

XVIVO.ST

3XV.F

0RKL.L
-2.01%
Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology

ACCESS Newswire 5mo ago

XVIVO.ST

3XV.F

0RKL.L
-2.01%
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

ACCESS Newswire 6mo ago

XVIVO.ST

0RKL.L
-2.01%
3XV.F
Xvivo Perfusion AB (XVIPF) Q2 2026 Earnings Call Highlights: Strong Organic Growth Amidst ...

GuruFocus.com 3mo ago

XVIVO.ST
Exploring European Undervalued Small Caps With Insider Action In June 2026

Simply Wall St. 4mo ago

^STOXX

NMAN.ST

NOHO.HE

U.S. markets close in 1h 26m

Xvivo Perfusion AB (publ) (0RKL.L)

Interim Report January - September 2026

Conference call on Interim Report July-September 2026

Nomination Committee of XVIVO Perfusion AB (publ)

XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System

XVIVO Receives CE Certificates for Its Groundbreaking Heart Preservation Technology, Transforming Access to Life-Saving Transplants Across Europe

XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport

Interim Report January - June 2026

Conference call on Interim Report April-June 2026

Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology

XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

Xvivo Perfusion AB (XVIPF) Q2 2026 Earnings Call Highlights: Strong Organic Growth Amidst ...

Exploring European Undervalued Small Caps With Insider Action In June 2026